Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function

Neuroscience

Volumn 116, Issue 1, 2003, Pages 127-137

  Matsumoto, M ^a   Weickert, C Shannon ^a   Akil, M ^a   Lipska, B K ^a   Hyde, T M ^a   Herman, M M ^a   Kleinman, J E ^a   Weinberger, D R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Dopamine; Functional polymorphism; Midbrain schizophrenia; Prefrontal cortex; Striatum

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN LEVEL; BRAIN NERVE CELL; BRAIN VENTRICLE; CELL FUNCTION; CELL SUBPOPULATION; CHOROID PLEXUS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EPENDYMA CELL; FOREBRAIN; GLIA; HIPPOCAMPUS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL TRACT; RAT;

ANIMALS; BLOTTING, NORTHERN; BRAIN CHEMISTRY; CATECHOL O-METHYLTRANSFERASE; CORPUS STRIATUM; HUMANS; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; NEURONS; PREFRONTAL CORTEX; PROSENCEPHALON; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0037439153     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00556-0     Document Type: Article

References (70)

1. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry. 156:1999;1580-1589.
2. Axelrod J., Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem. 233:1958;702-705.
3. Bergson C., Mrzljak L., Smiley J.F., Pappy M., Levenson R., Goldman-Rakic P.S. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci. 15:1995;7821-7836.
4. Bertocci B., Miggiano V., Da Prada M., Dembic Z., Lahm H.W., Malherbe P. Human catechol O-methyltransferase Cloning and expression of the membrane-associated form . Proc Natl Acad Sci USA. 88:1991;1416-1420.
5. Busch A.E., Karbach U., Miska D., Gorboulev V., Akhoundova A., Volk C., Arndt P., Ulzheimer J.C., Sonders M.S., Baumann C., Waldegger S., Lang F., Koepsell H. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 54:1998;342-352.
6. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542.
7. DeArmond S.J., Fusco M.M., Dewey M.M. Structure of the human brain. 1989;Oxford University Press, New York.
8. Diop L., Gottberg E., Briere R., Grondin L., Reader T.A. Distribution of dopamine D1 receptors in rat cortical areas, neostriatum, olfactory bulb and hippocampus in relation to endogenous dopamine contents. Synapse. 2:1988;395-405.
9. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 98:2001;6917-6922.
10. Eisenberg J., Mei-Tal G., Steinberg A., Tartakovsky E., Zohar A., Gritsenko I., Nemanov L., Ebstein R.P. Haplotype relative risk study of catechol O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD) Association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype . Am J Med Genet. 88:1999;497-502.
11. Falkenburger B.H., Barstow K.L., Mintz I.M. Dendrodendritic inhibition through reversal of dopamine transport. Science. 293:2001;2465-2470.
12. Gao W.J., Krimer L.S., Goldman-Rakic P.S. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci USA. 98:2001;295-300.
13. Garris P.A., Collins L.B., Jones S.R., Wightman R.M. Evoked extracellular dopamine in vivo in the medial prefrontal cortex. J Neurochem. 61:1993;637-647.
14. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
15. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA. 95:1998;9991-9996.
16. Goldman-Rakic P.S. The "psychic" neuron of the cerebral cortex. Ann NY Acad Sci. 868:1999;13-26.
17. Hartmann E., Wiedmann M., Rapoport T.A. A membrane component of the endoplasmic reticulum that may be essential for protein translocation. EMBO J. 8:1989;2225-2229.
18. Hong J., Shu-Leong H., Tao X., Lap-Ping Y. Distribution of catechol O-methyltransferase expression in human central nervous system. Neuroreport. 9:1998;2861-2864.
19. Joh T.H., Son J.H., Tinti C., Conti B., Kim S.J., Cho S. Unique and cell-type-specific tyrosine hydroxylase gene expression. Adv Pharmacol. 42:1998;33-36.
20. Jones G., Zammit S., Norton N., Hamshere M.L., Jones S.J., Milham C., Sanders R.D., McCarthy G.M., Jones L.A., Cardno A.G., Gray M., Murphy K.C., Owen M.J. Aggressive behaviour in patients with schizophrenia is associated with catechol O-methyltransferase genotype. Br J Psychiatry. 179:2001;351-355.
21. Kaakkola S., Mannisto P.T., Nissinen E. Striatal membrane-bound and soluble catechol O-methyl-transferase after selective neuronal lesions in the rat. J Neural Trans. 69:1987;221-228.
22. Kaplan G.P., Hartman B.K., Creveling C.R. Immunohistochemical demonstration of catechol O-methyltransferase in mammalian brain. Brain Res. 167:1979;241-250.
23. Kaplan G.P., Hartman B.K., Creveling C.R. Localization of catechol O-methyltransferase in the leptomeninges, choroid plexus and ciliary epithelium Implications for the separation of central and peripheral catechols . Brain Res. 204:1981;353-360.
24. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., Gogos J.A. Genotype determining low catechol O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA. 94:1997;4572-4575.
25. Karhunen T., Tilgmann C., Ulmanen I., Julkunen I., Panula P. Distribution of catechol O-methyltransferase enzyme in rat tissues. J Histochem Cytochem. 42:1994;1079-1090.
26. Karhunen T., Tilgmann C., Ulmanen I., Panula P. Catechol O-methyltransferase (COMT) in rat brain Immunoelectron microscopic study with an antiserum against rat recombinant COMT protein . Neurosci Lett. 187:1995;57-60.
27. Karoum F., Chrapusta S.J., Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model . J Neurochem. 63:1994;972-979.
28. Kastner A., Anglade P., Bounaix C., Daimer P., Javoy-Agid F., Bromet N., Agid Y., Hirsch E.C. Immunohistochemical study of catechol O-methyltransferase in the human mesostriatal system. Neuroscience. 62:1994;449-457.
29. Khan Z.U., Gutierrez A., Martin R., Penafiel A., Rivera A., de la Calle A. Dopamine D5 receptors of rat and human brain. Neuroscience. 100:2000;689-699.
30. Kleinman J.E., Hyde T.M., Herman M.M. Methodological issues in the neuropathology of mental illness. Bloom F.E., Kupfer D.I. Psychopharmacology The fourth generation of progress . 1995;859-864 Raven Press, New York.
31. Kunugi H., Vallada H.P., Sham P.C., Hoda F., Arranz M.J., Li T., Nanko S., Murray R.M., McGuffin P., Owen M., Gill M., Collier D.A. Catechol O-methyltransferase polymorphisms and schizophrenia A transmission disequilibrium study in multiply affected families . Psychiatr Genet. 7:1997;97-101.
32. Lewis D.A., Melchitzky D.S., Sesack S.R., Whitehead R.E., Auh S., Sampson A. Dopamine transporter immunoreactivity in monkey cerebral cortex Regional, laminar, and ultrastructural localization . J Comp Neurol. 432:2001;119-136.
33. Li T., Ball D., Zhao J., Murray R.M., Liu X., Sham P.C., Collier D.A. Family-based linkage disequilibrium mapping using SNP marker haplotypes Application to a potential locus for schizophrenia at chromosome 22q11 . Mol Psychiatry. 5:2000;77-84.
34. Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., Liu X., Collier D.A. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet. 6:1996;131-133.
35. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase A revised mechanism and description of the thermolabile variant of the enzyme . Biochemistry. 34:1995;4202-4210.
36. Lundstrom K., Tenhunen J., Tilgmann C., Karhunen T., Panula P., Ulmanen I. Cloning, expression and structure of catechol O-methyltransferase. Biochim Biophys Acta. 1251:1995;1-10.
37. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T.E., Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 159:2002;652-654.
38. Mannisto P.T., Kaakkola S. Catechol O-methyltransferase (COMT) biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors . Pharmacol Rev. 51:1999;593-628.
39. Matsumoto M., Hidaka K., Tada S., Tasaki Y., Yamaguchi T. Full-length cDNA cloning and distribution of human dopamine D4 receptor. Brain Res Mol Brain Res. 29:1995;157-162.
40. Mattay V.S., Fera F., Tessitore A., Hariri A.R., Das S., Callicott J.H., Weinberger D.R. Neurophysiological correlates of age-related changes in human motor function. Neurology. 58:2002;630-635.
41. Mattay V.S., Tessitore A., Callicott J.H., Bertolino A., Goldberg T.E., Chase T.N., Hyde T.M., Weinberger D.R. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol. 51:2002;156-164.
42. Montague D.M., Striplin C.D., Overcash J.S., Drago J., Lawler C.P., Mailman R.B. Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice. Synapse. 39:2001;319-322.
43. Moron J.A., Brockington A., Wise R.A., Rocha B.A., Hope B.T. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter Evidence from knock-out mouse lines . J Neurosci. 22:2002;389-395.
44. Palmatier M.A., Kang A.M., Kidd K.K. Global variation in the frequencies of functionally different catechol O-methyltransferase alleles. Biol Psychiatry. 46:1999;557-567.
45. Papolos D.F., Veit S., Faedda G.L., Saito T., Lachman H.M. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry. 3:1998;346-349.
46. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry. 49:1992;975-982.
47. Paxinos G., Huang X.F. The human brainstem. 1995;Academic Press, San Diego.
48. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
49. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex. I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex. 5:1995;307-322.
50. Rivett A.J., Francis A., Roth J.A. Distinct cellular localization of membrane-bound and soluble forms of catechol O-methyltransferase in brain. J Neurochem. 40:1983;215-219.
51. Rivett A.J., Francis A., Roth J.A. Localization of membrane-bound catechol O-methyltransferase. J Neurochem. 40:1983;1494-1496.
52. Rivett A.J., Roth J.A. Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol-O-methyltransferase. Biochemistry. 21:1982;1740-1742.
53. Rosa A., Zarzuela A., Cuesta M., Peralta V., Martinez-Larrea A., Serrano F., Fananas L. New evidence for association between COMT gene and prefrontal neurocognitive functions in schizophrenia. Schizophr Res. 53:(Suppl):2002;69-70.
54. Roth J.A. Membrane-bound catechol O-methyltransferase A reevaluation of its role in the O-methylation of the catecholamine neurotransmitters . Rev Physiol Biochem Pharmacol. 120:1992;1-29.
55. Saavedra J.M., Brownstein M.J., Palkovits M. Distribution of catechol O-methyltransferase, histamine N-methyltransferase and monoamine oxidase in specific areas of the rat brain. Brain Res. 118:1976;152-156.
56. Seamans J.K., Durstewitz D., Christie B.R., Stevens C.F., Sejnowski T.J. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA. 98:2001;301-306.
57. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci. 18:1998;2697-2708.
58. Tenhunen J., Salminen M., Jalanko A., Ukkonen S., Ulmanen I. Structure of the rat catechol O-methyltransferase gene Separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme . DNA Cell Biol. 12:1993;253-623.
59. Tenhunen J., Salminen M., Lundstrom K., Kiviluoto T., Savolainen R., Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem. 223:1994;1049-1059.
60. Ulmanen I., Lundstrom K. Cell-free synthesis of rat and human catechol O-methyltransferase. Insertion of the membrane-bound form into microsomal membranes in vitro. Eur J Biochem. 202:1991;1013-1020.
61. Ulmanen I., Peranen J., Tenhunen J., Tilgmann C., Karhunen T., Panula P., Bernasconi L., Aubry J.P., Lundstrom K. Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells. Eur J Biochem. 243:1997;452-459.
62. Vandenbergh D.J., Rodriguez L.A., Miller I.T., Uhl G.R., Lachman H.M. High-activity catechol O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet. 74:1997;439-442.
63. Wayment H.K., Schenk J.O., Sorg B.A. Characterization of extracellular dopamine clearance in the medial prefrontal cortex Role of monoamine uptake and monoamine oxidase inhibition . J Neurosci. 21:2001;35-44.
64. Weinberger D.R., Berman K.F. Prefrontal function in schizophrenia Confounds and controversies . Philos Trans R Soc Lond B Biol Sci. 351:1996;1495-1503.
65. Weinberger D.R., Berman K.F., Chase T.N. Mesocortical dopaminergic function and human cognition. Ann NY Acad Sci. 537:1988;330-338.
66. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., Berman K.F., Goldberg T.E. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry. 50:2001;825-844.
67. Wexler B.E., Stevens A.A., Bowers A.A., Sernyak M.J., Goldman-Rakic P.S. Word and tone working memory deficits in schizophrenia. Arch Gen Psychiatry. 55:1998;1093-1096.
68. Whitfield H.J. Jr., Brady L.S., Smith M.A., Mamalaki E., Fox R.J., Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain A detailed protocol . Cell Mol Neurobiol. 10:1990;145-157.
69. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
70. Wu X., Kekuda R., Huang W., Fei Y.J., Leibach F.H., Chen J., Conway S.J., Ganapathy V. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem. 273:1998;32776-32786.